HC Wainwright Has Positive Outlook for SLGL Q3 Earnings

Key Points

• HC Wainwright raised its Q3 2026 EPS estimate for Sol-Gel Technologies to a loss of $1.54 per share from a projected loss of $1.71, while maintaining a “Buy” rating. The firm forecasts a $4.92 per-share loss for full-year 2027.
• Analyst sentiment is generally positive, with MarketBeat reporting a “Moderate Buy” consensus rating and an average price target of $197.50, despite one “Sell” rating.
• Sol-Gel reported a better-than-expected quarterly loss of $1.13 per share and revenue of $0.59 million. The stock opened at $71.94, while insiders own 66.51% of the company and recently increased their holdings.

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Free Report) - HC Wainwright boosted their Q3 2026 EPS estimates for shares of Sol-Gel Technologies in a research note issued to investors on Tuesday, October 6th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($1.54) per share for the quarter, up from their previous estimate of ($1.71). HC Wainwright has a "Buy" rating on the stock. The consensus estimate for Sol-Gel Technologies' current full-year earnings is ($4.95) per share. HC Wainwright also issued estimates for Sol-Gel Technologies' Q4 2026 earnings at ($1.77) EPS, Q1 2027 earnings at ($1.14) EPS, Q2 2027 earnings at ($1.08) EPS, Q4 2027 earnings at ($1.41) EPS and FY2027 earnings at ($4.92) EPS.

A number of other research analysts also recently weighed in on the stock. Weiss Ratings restated a "sell (d-)" rating on shares of Sol-Gel Technologies in a report on Tuesday, September 1st. Mizuho initiated coverage on Sol-Gel Technologies in a research report on Wednesday, June 24th. They issued an "outperform" rating and a $285.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $197.50.

Sol-Gel Technologies Price Performance

SLGL opened at $71.94 on Thursday. The company has a market capitalization of $202.15 million, a PE ratio of -12.76 and a beta of 1.14. The business has a 50-day moving average of $73.58 and a 200-day moving average of $74.35. Sol-Gel Technologies has a fifty-two week low of $28.81 and a fifty-two week high of $97.97.

Sol-Gel Technologies (NASDAQ:SLGL - Get Free Report) last posted its quarterly earnings results on Friday, August 21st. The company reported ($1.13) earnings per share for the quarter, topping analysts' consensus estimates of ($2.36) by $1.23. The business had revenue of $0.59 million for the quarter, compared to the consensus estimate of $0.07 million. Sol-Gel Technologies had a negative net margin of 910.14% and a negative return on equity of 44.05%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Sol-Gel Technologies stock. Affinity Asset Advisors LLC bought a new position in shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 35,000 shares of the company's stock, valued at approximately $2,773,000. Affinity Asset Advisors LLC owned 1.25% of Sol-Gel Technologies at the end of the most recent quarter. Hedge funds and other institutional investors own 26.18% of the company's stock.

Insider Activity at Sol-Gel Technologies

In other Sol-Gel Technologies news, major shareholder Opaleye Management Inc. acquired 35,113 shares of the business's stock in a transaction that occurred on Friday, August 28th. The stock was acquired at an average price of $69.32 per share, with a total value of $2,434,033.16. Following the transaction, the insider owned 520,000 shares of the company's stock, valued at approximately $36,046,400. This trade represents a 7.24% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders bought 53,659 shares of company stock valued at $3,701,674 in the last 90 days. Insiders own 66.51% of the company's stock.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd. NASDAQ: SLGL is an Israeli specialty pharmaceutical company focused on developing and commercializing topical dermatological treatments. The company uses proprietary silica-based microsponge technology designed to encapsulate and gradually release active pharmaceutical ingredients in the skin.

Its marketed products include TWYNEO, a topical cream combining tretinoin and benzoyl peroxide for the treatment of acne vulgaris, and EPSOLAY, a topical benzoyl peroxide cream for the treatment of inflammatory lesions associated with rosacea.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.